JNJ Strong buy
Good earnings. Rising dividends for 52 years. Doing well in Biotech, an up and coming sector. Hopefully it will start doing some more small M&A deals and release the 10 blockbusters it said it will over the next 5 years. 
JNJ
JNJ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.